P. Hammerer

879 total citations
49 papers, 624 citations indexed

About

P. Hammerer is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology. According to data from OpenAlex, P. Hammerer has authored 49 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 8 papers in Urology. Recurrent topics in P. Hammerer's work include Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (29 papers) and Urologic and reproductive health conditions (11 papers). P. Hammerer is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (29 papers) and Urologic and reproductive health conditions (11 papers). P. Hammerer collaborates with scholars based in Germany, United States and Canada. P. Hammerer's co-authors include Hartwig Huland, Markus Graefen, Michael W. Kattan, Wolfgang Hoeltl, L Boccon-Gibod, Bob Djavan, U. W. Tunn, Pierre Teillac, Tommaso Prayer‐Galetti and Alexander Haese and has published in prestigious journals such as The Journal of Urology, European Urology and British Journal of Urology.

In The Last Decade

P. Hammerer

41 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Hammerer Germany 12 521 290 218 126 46 49 624
Vahan Kassabian United States 6 501 1.0× 156 0.5× 91 0.4× 93 0.7× 40 0.9× 16 580
M.M. Lieber United States 10 365 0.7× 154 0.5× 106 0.5× 115 0.9× 75 1.6× 17 504
Zachariah A. Allen United States 22 1.2k 2.2× 193 0.7× 274 1.3× 224 1.8× 96 2.1× 61 1.3k
H.Ballentine Carter United States 10 618 1.2× 167 0.6× 92 0.4× 135 1.1× 108 2.3× 12 767
D. van den Ouden Netherlands 8 341 0.7× 328 1.1× 199 0.9× 271 2.2× 25 0.5× 12 554
Gunna Aus Sweden 4 569 1.1× 153 0.5× 59 0.3× 113 0.9× 105 2.3× 8 653
Paul A. Peller United States 6 316 0.6× 132 0.5× 90 0.4× 76 0.6× 23 0.5× 8 408
John E. Garnett United States 12 341 0.7× 111 0.4× 80 0.4× 168 1.3× 85 1.8× 13 457
Jonathan Brajtbord United States 12 387 0.7× 133 0.5× 59 0.3× 101 0.8× 39 0.8× 22 464
Francesco Pellegrino Italy 11 449 0.9× 178 0.6× 70 0.3× 98 0.8× 47 1.0× 46 560

Countries citing papers authored by P. Hammerer

Since Specialization
Citations

This map shows the geographic impact of P. Hammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hammerer more than expected).

Fields of papers citing papers by P. Hammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hammerer. The network helps show where P. Hammerer may publish in the future.

Co-authorship network of co-authors of P. Hammerer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hammerer. A scholar is included among the top collaborators of P. Hammerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hammerer. P. Hammerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammerer, P., Philipp Ivanyi, Marco J. Schnabel, et al.. (2024). P260 Real-world data on treatment patterns and guideline adherence in patients with locally advanced and metastatic urothelial bladder cancer (la/mUC) in Germany. European Urology Open Science. 69. 328–329.
2.
Kopp, Joachim, Lukas Manka, Andreas Beck, et al.. (2020). 68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy. World Journal of Urology. 38(12). 3085–3090. 18 indexed citations
3.
4.
Schiffmann, Jonas, Pierre I. Karakiewicz, Michael Rink, et al.. (2018). Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients. World Journal of Urology. 36(7). 1067–1072. 19 indexed citations
5.
Tokas, Theodoros, P. Hammerer, Ludger Franzaring, et al.. (2015). Prostatabiopsie. Der Urologe. 54(12). 1811–1822.
6.
Brill, Florian H. H., et al.. (2012). Der Einfluss der Viskosität von künstlichem Harn auf die Durchflussgeschwindigkeit in Kathetern. Der Urologe. 51(3). 403–408. 2 indexed citations
7.
Boccon-Gibod, L, Bob Djavan, P. Hammerer, et al.. (2004). Management of prostate-specific antigen relapse in prostate cancer: A European consensus. International Journal of Clinical Practice. 58(4). 382–390. 89 indexed citations
8.
Augustin, Herbert, Andreas Erbersdobler, Markus Graefen, et al.. (2003). Differences in biopsy features between prostate cancers located in the transition and peripheral zone. British Journal of Urology. 91(6). 477–481. 29 indexed citations
9.
Graefen, Markus, P. Hammerer, Alexander Haese, & Hartwig Huland. (2003). Indikationstellung und Ergebnisse der radikalen Prostatektomie. Der Urologe. 42(9). 1203–1211. 4 indexed citations
10.
Augustin, Herbert, Pierre I. Karakiewicz, P. Hammerer, et al.. (2003). Sind statistische Vorhersagemodelle aus den USA auf deutsche Patienten übertragbar?. Der Urologe. 42(5). 685–692. 8 indexed citations
11.
Steuber, Thomas, et al.. (2002). Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146. Oxford University Research Archive (ORA) (University of Oxford). 25. 67–69. 1 indexed citations
12.
Erbersdobler, Andreas, Jüri Palisaar, Markus Graefen, et al.. (2002). Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone. Prostate Cancer and Prostatic Diseases. 5(4). 279–284. 11 indexed citations
13.
Hammerer, P., et al.. (2000). Ratio free/total PSA (%f-PSA) in men with total PSA 0.5–3 ng/ml: improvement for prostate cancer detection?. Prostate Cancer and Prostatic Diseases. 3(S1). S19–S19. 8 indexed citations
14.
Graefen, Markus, P. Hammerer, Alexander Haese, & Hartwig Huland. (2000). Therapieoptionen des hormonrefraktären Prostatakarzinoms. Der Urologe. 39(3). 267–273. 1 indexed citations
15.
Graefen, Markus, et al.. (2000). A validated strategy to select patients for a nerve-sparing radical prostatectomy. Prostate Cancer and Prostatic Diseases. 3(S1). S18–S18. 1 indexed citations
16.
Erbersdobler, Andreas, et al.. (1999). Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality. Prostate Cancer and Prostatic Diseases. 2(4). 204–210. 8 indexed citations
17.
18.
Hammerer, P., et al.. (1992). Digital Rectal Examination, Imaging, and Systematic- Sextant Biopsy in Identifying Operable Lymph Node-Negative Prostatic Carcinoma. European Urology. 22(4). 281–287. 38 indexed citations
19.
Hamm, Bernd, et al.. (1991). Diagnostik von Harnblasenkarzinomen in der Kernspintomographie: Verbesserung mit Gd-DTPA?. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 155(8). 117–122. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vahan Kassabian Breakdown of academic impact, for papers by M.M. Lieber Breakdown of academic impact, for papers by Zachariah A. Allen Breakdown of academic impact, for papers by H.Ballentine Carter Breakdown of academic impact, for papers by D. van den Ouden Breakdown of academic impact, for papers by Gunna Aus Breakdown of academic impact, for papers by Paul A. Peller Breakdown of academic impact, for papers by John E. Garnett Breakdown of academic impact, for papers by Jonathan Brajtbord Breakdown of academic impact, for papers by Francesco Pellegrino
Rankless by CCL
2026